EAM
ICPT

Erste Asset Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Erste Asset Management’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-13,950
Closed -$1.52M – 444
2018
Q4 		$1.3M Buy
+13,950
New +$1.45M 0.09% 211

Other funds holding ICPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Erste Asset Management's ICPT Position: Q1 2019 in Review

Erste Asset Management sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q1 2019, closing a stake of 13,950 shares — an estimated $1.52M sold.

Erste Asset Management first reported a position in ICPT in Q4 2018 and held it in 1 quarter. The position peaked at $1.3M in Q4 2018. 202 funds tracked by Wall St. Rank hold ICPT as of Q1 2019.

  • Erste Asset Management reported no remaining Intercept Pharmaceuticals, Inc. position as of Q1 2019 after selling out during the quarter.
  • Erste Asset Management sold 13,950 Intercept Pharmaceuticals, Inc. shares in Q1 2019, an estimated $1.52M.
  • Erste Asset Management first reported a position in Intercept Pharmaceuticals, Inc. in Q4 2018 and held it in 1 quarter.
  • Erste Asset Management's Intercept Pharmaceuticals, Inc. position peaked at $1.3M in Q4 2018.
  • 202 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q1 2019.

Based on Erste Asset Management's 13F filing for Q1 2019, filed 22 Nov 2024.